Margins too should move up as the proportion of these segments improves in the revenue mix
While Q3 performance beat Street estimates, O2C is key to sustaining growth this year
Brokerages cut earnings given pressure on margins but see stock performing in long term
It is expected to support its rich valuations
Near-term growth concerns, too, weighed on the stock
Q3 could see weak volumes; hurdle for incumbents is new entrants in the sector
Market share gains in the Indian market and margin expansion are other positives
Margins expected to bottom out; brokerages prefer category leaders
Brokerages are neutral on the stock given near term challenges and valuations
Higher sales, improving cash flows are expected to drive further debt reduction for the sector
Kotak Institutional Equities believes that Q3 for speciality chemicals will be a mixed bag, with weak earnings from most players in the crop protection space
The quarterly update indicates strong sales momentum across geographies
Brokerages have a mixed view on the stock; scale up of foods segment key for further gains
Higher exports and improving margins on the back of softening input costs are other positives
Steady outlook and higher returns triggers for companies refining their strategy
Keep your portfolio safe for 2023 with these 10 blue-chip bargains
The stock has recovered some lost ground since November, as the Glyphosate herbicide overhang is behind for now
Margins for state-owned firm that specialises in missiles would be range bound given higher raw material costs
Brokerages have a mixed outlook on margin trajectory for the sector
The company is selling its loss-making German CV forging business